newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it has completed the previously announced 1-for-20 reverse stock split of its outstanding and authorized shares of common stock. The reverse stock split